Codexis Inc (CDXS)vsInsmed Inc (INSM)
CDXS
Codexis Inc
$1.67
+3.73%
HEALTHCARE · Cap: $145.39M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 762% more annual revenue ($606.42M vs $70.39M). INSM leads profitability with a -2.1% profit margin vs -62.5%. CDXS earns a higher WallStSmart Score of 47/100 (D+).
CDXS
Hold47
out of 100
Grade: D+
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 35.9%
Revenue surging 81.3% year-over-year
Reasonable price relative to book value
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -74.9% — below average capital efficiency
Currently unprofitable
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CDXS
The strongest argument for CDXS centers on Operating Margin, Revenue Growth, Price/Book. Revenue growth of 81.3% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : CDXS
The primary concerns for CDXS are EPS Growth, Market Cap, Return on Equity.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
CDXS profiles as a hypergrowth stock while INSM is a turnaround play — different risk/reward profiles.
CDXS carries more volatility with a beta of 2.50 — expect wider price swings.
CDXS is growing revenue faster at 81.3% — sustainability is the question.
CDXS generates stronger free cash flow (20M), providing more financial flexibility.
Bottom Line
CDXS scores higher overall (47/100 vs 39/100) and 81.3% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Codexis Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?